2026-04-28 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, April 28, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) announces an educational webinar exploring the evolution of PSMA[1]-targeted radionuclide therapy and Telix’s differentiated, multi-product approach to…
